Inovio Pharmaceuticals
INO
#9158
Rank
โ‚ฌ97.29 M
Marketcap
1,42ย โ‚ฌ
Share price
-1.18%
Change (1 day)
-25.81%
Change (1 year)

Revenue for Inovio Pharmaceuticals (INO)

Revenue in 2025 (TTM): โ‚ฌ0.17 Million

According to Inovio Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.15 Million. In 2024 the company made a revenue of โ‚ฌ0.2 Million a decrease over the revenue in the year 2023 that were of โ‚ฌ0.75 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Inovio Pharmaceuticals from 1999 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ0.17 M-17.41%
2024 โ‚ฌ0.2 M-72.2%
2023 โ‚ฌ0.75 M-92.13%
2022 โ‚ฌ9.56 M510.49%
2021 โ‚ฌ1.56 M-73.99%
2020 โ‚ฌ6.02 M64.15%
2019 โ‚ฌ3.67 M-86.22%
2018 โ‚ฌ26.64 M-24.28%
2017 โ‚ฌ35.18 M4.65%
2016 โ‚ฌ33.62 M-9.38%
2015 โ‚ฌ37.1 M331.58%
2014 โ‚ฌ8.59 M-11.83%
2013 โ‚ฌ9.75 M213.2%
2012 โ‚ฌ3.11 M-58.72%
2011 โ‚ฌ7.54 M63.27%
2010 โ‚ฌ4.61 M-27.43%
2009 โ‚ฌ6.36 M324.25%
2008 โ‚ฌ1.5 M-54.43%
2007 โ‚ฌ3.29 M25.27%
2006 โ‚ฌ2.62 M-43.05%
2005 โ‚ฌ4.61 M436.43%
2004 โ‚ฌ0.86 M1245.12%
2003 โ‚ฌ0.06 M-64.72%
2002 โ‚ฌ0.18 M
2000 โ‚ฌ5.9 M-32.44%
1999 โ‚ฌ8.74 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ78.14 B 50,537,640.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ47.80 B 30,916,280.11%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚ฌ53.24 B 34,433,942.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ24.66 B 15,951,681.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ54.47 B 35,228,624.83%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚ฌ35.91 B 23,227,647.08%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cleveland BioLabs
CBLI
โ‚ฌ0.53 M 246.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
โ‚ฌ0.70 B 454,798.35%๐Ÿ‡บ๐Ÿ‡ธ USA